Cargando…
Reversal of direct oral anticoagulants in hemophilia treatment: ASH meeting 2015
During the 57(th) annual meeting of the American Society of Hematology 2015 in Orlando, Florida, various aspects in the field of hemostaseology were presented. The Choosing Wisely® campaign pointed out the importance of the critical use of diagnostic tools to rule out pulmonary embolism and question...
Autores principales: | Feistritzer, Clemens, Schmidt, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045483/ https://www.ncbi.nlm.nih.gov/pubmed/27752290 http://dx.doi.org/10.1007/s12254-016-0284-2 |
Ejemplares similares
-
ASH Meeting 2016: developments in hemostaseology
por: Feistritzer, Clemens, et al.
Publicado: (2017) -
Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017) -
The Reversal of Direct Oral Anticoagulants in Animal Models
por: Honickel, Markus, et al.
Publicado: (2017) -
Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
por: Kustos, Stephanie A., et al.
Publicado: (2019) -
Pain management in hemophilia: expert recommendations
por: Stromer, Waltraud, et al.
Publicado: (2021)